Peptidomimetic-based antibody surrogate for HER2

Inhibition of human epidermal growth factor receptor 2 mediated cell signaling pathway is an important therapeutic strategy for HER2-positive cancers. Although monoclonal antibodies are currently used as marketed drugs, their large molecular weight, high cost of production and susceptibility to prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Mengmeng, Li, Chunpu, Zhou, Mi, Jia, Ru, She, Fengyu, Wei, Lulu, Cheng, Feng, Li, Qi, Cai, Jianfeng, Wang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463277/
https://www.ncbi.nlm.nih.gov/pubmed/34589386
http://dx.doi.org/10.1016/j.apsb.2021.04.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463277/
https://www.ncbi.nlm.nih.gov/pubmed/34589386
http://dx.doi.org/10.1016/j.apsb.2021.04.016

Ejemplares similares